Showing results (51-60 of 120) with videos related to
Sort By:
Pageof 12
Progress in Clinical and Biological Research|January 1, 1986
Comparative cost analysis of home and hospital treatmentV Vinciguerra, T J Degnan, D R Budman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with responseW Kreis, M Lesser, D R Budman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancerJ Aisner, M Y Whitacre, D R Budman, et al.Cancer Research|October 1, 1988
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemiaW Kreis, C Rottach, D R Budman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of vinzolidineW Kreis, D R Budman, P Schulman, et al.International Journal of Cell Cloning|September 1, 1983
Modulation of human tumor colony growth in soft agar by serumA W Hamburger, C P White, F E Dunn, et al.Cancer Investigation|December 7, 2000
Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitroD R Budman, A Calabro, L G Wang, et al.Journal of Clinical Gastroenterology|October 1, 1987
Flow cytometry. A new technique in the diagnosis of malignant ascitesG S Weissman, M J McKinley, D R Budman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsW Kreis, D R Budman, V Vinciguerra, et al.Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.Pageof 12